Xingbo Mo

2.7k total citations · 1 hit paper
68 papers, 1.4k citations indexed

About

Xingbo Mo is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Xingbo Mo has authored 68 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 25 papers in Cancer Research and 16 papers in Genetics. Recurrent topics in Xingbo Mo's work include Cancer-related molecular mechanisms research (21 papers), RNA modifications and cancer (19 papers) and Genetic Associations and Epidemiology (11 papers). Xingbo Mo is often cited by papers focused on Cancer-related molecular mechanisms research (21 papers), RNA modifications and cancer (19 papers) and Genetic Associations and Epidemiology (11 papers). Xingbo Mo collaborates with scholars based in China, United States and Taiwan. Xingbo Mo's co-authors include Shu‐Feng Lei, Dongfeng Gu, Yonghong Zhang, Jianfeng Huang, Xueli Yang, Jie Cao, Xiaohua Liang, Fei‐Yan Deng, Huan Zhang and Xiangfeng Lu and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and Journal of Ethnopharmacology.

In The Last Decade

Xingbo Mo

63 papers receiving 1.4k citations

Hit Papers

Effect of mobile phone intervention for diabetes on glyca... 2010 2026 2015 2020 2010 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingbo Mo China 19 581 311 310 284 179 68 1.4k
Sarah B. Peskoe United States 23 441 0.8× 316 1.0× 95 0.3× 94 0.3× 95 0.5× 83 1.5k
Jian Lu China 21 310 0.5× 187 0.6× 85 0.3× 96 0.3× 72 0.4× 55 1.2k
David C. Muller United Kingdom 25 660 1.1× 268 0.9× 42 0.1× 192 0.7× 85 0.5× 62 1.9k
Zefeng Xu China 24 569 1.0× 135 0.4× 49 0.2× 152 0.5× 104 0.6× 169 1.8k
Chan Zeng United States 27 748 1.3× 141 0.5× 236 0.8× 200 0.7× 20 0.1× 63 2.4k
Harry Hahmann Germany 16 784 1.3× 198 0.6× 78 0.3× 220 0.8× 35 0.2× 43 2.0k
Keun-Young Yoo South Korea 27 751 1.3× 330 1.1× 44 0.1× 143 0.5× 91 0.5× 82 2.1k
Clara Chen United States 24 604 1.0× 192 0.6× 47 0.2× 155 0.5× 184 1.0× 101 2.6k
Ángel Ferrández Spain 23 429 0.7× 116 0.4× 65 0.2× 281 1.0× 37 0.2× 76 1.8k
Min Nie China 22 587 1.0× 58 0.2× 160 0.5× 469 1.7× 71 0.4× 130 1.6k

Countries citing papers authored by Xingbo Mo

Since Specialization
Citations

This map shows the geographic impact of Xingbo Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingbo Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingbo Mo more than expected).

Fields of papers citing papers by Xingbo Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingbo Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingbo Mo. The network helps show where Xingbo Mo may publish in the future.

Co-authorship network of co-authors of Xingbo Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Xingbo Mo. A scholar is included among the top collaborators of Xingbo Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingbo Mo. Xingbo Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaomin, Tao Li, Xinyang Zhou, et al.. (2025). Hawthorn juice transforms notoginseng stem-leaf saponins: Synergistically regulates blood viscosity and ameliorates glycolipid metabolic disorders. Journal of Ethnopharmacology. 358. 120991–120991.
2.
Mo, Xingbo, et al.. (2024). Association of cardiorenal biomarkers with mortality in metabolic syndrome patients: A prospective cohort study from NHANES. Chronic Diseases and Translational Medicine. 10(4). 327–339.
3.
4.
Wang, Mimi, et al.. (2023). Genome-wide identification of RNA modification-related single nucleotide polymorphisms associated with rheumatoid arthritis. BMC Genomics. 24(1). 153–153. 10 indexed citations
5.
Li, Ru, Huan Zhang, Fan Tang, et al.. (2022). Coronary artery disease risk factors affected by RNA modification-related genetic variants. Frontiers in Cardiovascular Medicine. 9. 985121–985121. 8 indexed citations
6.
Wang, Mimi, Limin Han, Huan Zhang, et al.. (2022). RNA modification-related variants in genomic loci associated with body mass index. Human Genomics. 16(1). 25–25. 5 indexed citations
7.
Wu, Long‐Fei, Qin Zhang, Xingbo Mo, et al.. (2022). Identification of novel rheumatoid arthritis-associated MiRNA-204-5p from plasma exosomes. Experimental & Molecular Medicine. 54(3). 334–345. 54 indexed citations
8.
Wang, Aili, Mingzhi Zhang, Yi Ding, et al.. (2020). Associations of B‐Type Natriuretic Peptide and Its Coding Gene Promoter Methylation With Functional Outcome of Acute Ischemic Stroke: A Mediation Analysis. Journal of the American Heart Association. 9(18). e017499–e017499. 7 indexed citations
9.
Mo, Xingbo, et al.. (2020). Integrative analysis highlighted susceptibility genes for rheumatoid arthritis. International Immunopharmacology. 86. 106716–106716. 9 indexed citations
10.
Mo, Xingbo, Huan Zhang, Zhengyuan Zhou, et al.. (2019). SNPs rs10224002 in PRKAG2 may disturb gene expression and consequently affect hypertension. Molecular Biology Reports. 46(2). 1617–1624. 2 indexed citations
11.
Mo, Xingbo, Shu‐Feng Lei, Yonghong Zhang, & Huan Zhang. (2019). Examination of the associations between m6A-associated single-nucleotide polymorphisms and blood pressure. Hypertension Research. 42(10). 1582–1589. 47 indexed citations
12.
Mo, Xingbo, Shu‐Feng Lei, Yonghong Zhang, & Huan Zhang. (2019). Integrative Analysis Identified IRF6 and NDST1 as Potential Causal Genes for Ischemic Stroke. Frontiers in Neurology. 10. 517–517. 15 indexed citations
13.
Mo, Xingbo, Huan Zhang, Shu‐Feng Lei, et al.. (2018). Putative functional SNPs in SLC22A3 and H3F3B might influence the development of CAD by regulating the lipid levels. Thrombosis Research. 168. 37–39.
14.
Mo, Xingbo, Shu‐Feng Lei, Yonghong Zhang, & Huan Zhang. (2018). Genome-wide enrichment of m6A-associated single-nucleotide polymorphisms in the lipid loci. The Pharmacogenomics Journal. 19(4). 347–357. 28 indexed citations
15.
Mo, Xingbo, Yonghong Zhang, & Shu‐Feng Lei. (2018). Genome-Wide Identification of N6-Methyladenosine (m6A) SNPs Associated With Rheumatoid Arthritis. Frontiers in Genetics. 9. 299–299. 43 indexed citations
16.
Lu, Yihua, Wei Xia, Xingbo Mo, et al.. (2017). The distribution and functional relevance analysis of runs of homozygosity (ROHs) in Chinese Han female population. Molecular Genetics and Genomics. 293(1). 197–206. 2 indexed citations
17.
Wang, Lan, Long‐Fei Wu, Xin Lu, et al.. (2015). Integrated Analyses of Gene Expression Profiles Digs out Common Markers for Rheumatic Diseases. PLoS ONE. 10(9). e0137522–e0137522. 18 indexed citations
18.
Zhang, Huan, Xingbo Mo, Yongchen Hao, et al.. (2012). Adiponectin Levels and Risk of Coronary Heart Disease: A Meta-analysis of Prospective Studies. The American Journal of the Medical Sciences. 345(6). 455–461. 50 indexed citations
19.
Mo, Xingbo, Yongchen Hao, Xueli Yang, et al.. (2011). Association between polymorphisms in the coagulation factor VII gene and coronary heart disease risk in different ethnicities: a meta-analysis. BMC Medical Genetics. 12(1). 107–107. 25 indexed citations
20.
Hao, Yongchen, Xingbo Mo, Laiyuan Wang, et al.. (2010). PLA2G7 gene polymorphisms and coronary heart disease risk: A meta-analysis. Thrombosis Research. 126(6). 498–503. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026